The transformation of masculinity orientations and work-related attitudes in men treated for depression (TRANSMODE): study protocol for a mixed-methods observational study.
Depression
Dyadic coping
Latent transition analysis
Masculine orientations
Men´s depression
Mix-methods study
Partners of depressed men
Qualitative study
Work-related attitudes
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
10 07 2023
10 07 2023
Historique:
received:
17
05
2023
accepted:
22
06
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Masculinity norms play a crucial role in men's help-seeking behaviors, service-use, and coping strategies for depression. While previous studies provided evidence for the association between gender role orientations, work related attitudes, stigmatization of men with depression and depressive symptoms, it remains unclear to what extent gender role orientations change over time and whether psychiatric and psychotherapeutic treatment have an impact on these transformations. Additionally, the role of partners in supporting depressed men and the impact of dyadic coping on these processes have not been explored. The aim of this study is to investigate how masculinity orientations and work-related attitudes change over time in men treated for depression, and to examine the role of their partners and dyadic coping in these transformation processes. TRANSMODE is a prospective longitudinal mixed-methods study investigating the transformation of masculinity orientations and work-related attitudes in men treated for depression between the ages of 18 and 65 from different settings in Germany. The study will recruit 350 men from various settings for quantitative analysis. By applying a latent transition analysis, the primary outcome are changes in masculine orientations and work-related attitudes over time, measured at four times (t0, t1, t2, t3) with intervals of 6 months. Qualitative interview with a subsample of depressed men selected using latent profile analysis, will be conducted between t0 and t1 (a1) with a follow-up of 12 months (a2). In addition, qualitative interviews with the partners of depressed men will be conducted between t2 and t3 (p1). Qualitative data will be analysed using qualitative structured content analysis. A comprehensive understanding of the transformation processes of masculinity orientations over time including the impact of psychiatric/psychotherapeutic treatment and the role of partners can lead to the development of gender-sensitive depression treatment tailored to the unique needs of men with depression. Thus, the study can promote more effective and successful treatment outcomes and further contribute to reducing the stigma surrounding mental health issues among men and encourage them for mental health service use. This study is registered in the German Clinical Trail Register (DRKS) and the WHO International Clinical Trials Registry Platform (ICTRP) under registration number DRKS00031065 (Date of registration 06 February 2023).
Sections du résumé
BACKGROUND
Masculinity norms play a crucial role in men's help-seeking behaviors, service-use, and coping strategies for depression. While previous studies provided evidence for the association between gender role orientations, work related attitudes, stigmatization of men with depression and depressive symptoms, it remains unclear to what extent gender role orientations change over time and whether psychiatric and psychotherapeutic treatment have an impact on these transformations. Additionally, the role of partners in supporting depressed men and the impact of dyadic coping on these processes have not been explored. The aim of this study is to investigate how masculinity orientations and work-related attitudes change over time in men treated for depression, and to examine the role of their partners and dyadic coping in these transformation processes.
METHODS
TRANSMODE is a prospective longitudinal mixed-methods study investigating the transformation of masculinity orientations and work-related attitudes in men treated for depression between the ages of 18 and 65 from different settings in Germany. The study will recruit 350 men from various settings for quantitative analysis. By applying a latent transition analysis, the primary outcome are changes in masculine orientations and work-related attitudes over time, measured at four times (t0, t1, t2, t3) with intervals of 6 months. Qualitative interview with a subsample of depressed men selected using latent profile analysis, will be conducted between t0 and t1 (a1) with a follow-up of 12 months (a2). In addition, qualitative interviews with the partners of depressed men will be conducted between t2 and t3 (p1). Qualitative data will be analysed using qualitative structured content analysis.
DISCUSSION
A comprehensive understanding of the transformation processes of masculinity orientations over time including the impact of psychiatric/psychotherapeutic treatment and the role of partners can lead to the development of gender-sensitive depression treatment tailored to the unique needs of men with depression. Thus, the study can promote more effective and successful treatment outcomes and further contribute to reducing the stigma surrounding mental health issues among men and encourage them for mental health service use.
TRIAL REGISTRATION
This study is registered in the German Clinical Trail Register (DRKS) and the WHO International Clinical Trials Registry Platform (ICTRP) under registration number DRKS00031065 (Date of registration 06 February 2023).
Identifiants
pubmed: 37430236
doi: 10.1186/s12888-023-04979-3
pii: 10.1186/s12888-023-04979-3
pmc: PMC10331982
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
492Informations de copyright
© 2023. The Author(s).
Références
Nord J Psychiatry. 2002;56(4):265-71
pubmed: 12470317
Am J Mens Health. 2023 Mar-Apr;17(2):15579883231157971
pubmed: 36880329
Front Psychiatry. 2020 Nov 24;11:599039
pubmed: 33329149
Epidemiol Rev. 2008;30:118-32
pubmed: 18587142
Psychol Bull. 2017 Aug;143(8):783-822
pubmed: 28447828
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Saf Health Work. 2016 Dec;7(4):268-283
pubmed: 27924229
Eur Sociol Rev. 2016 Feb 1;32(1):39-53
pubmed: 26877572
Neuropsychiatr. 2008;22(1):43-8
pubmed: 18381057
Int J Environ Res Public Health. 2018 Jul 06;15(7):
pubmed: 29986446
BMC Public Health. 2017 Mar 16;17(1):264
pubmed: 28302088
Health Place. 2013 May;21:94-101
pubmed: 23454665
PLoS One. 2020 May 26;15(5):e0233764
pubmed: 32453783
Am J Mens Health. 2010 Jun;4(2):167-75
pubmed: 19477750
Psychopathology. 2017;50(2):107-124
pubmed: 28285304
Psychiatr Prax. 2020 Mar;47(2):65-70
pubmed: 31952090
Eur J Public Health. 2021 Dec 1;31(6):1223-1230
pubmed: 34254115
Am J Mens Health. 2018 Jan;12(1):104-116
pubmed: 26993998
Am J Mens Health. 2018 Sep;12(5):1247-1261
pubmed: 29708008
Psychiatr Prax. 2022 Nov;49(8):411-418
pubmed: 34826865
J Affect Disord. 2013 Dec;151(3):950-8
pubmed: 24051100
BMC Psychiatry. 2020 Jun 3;20(1):276
pubmed: 32493263
Front Psychol. 2022 Jun 10;13:876455
pubmed: 35756297
Clin Psychol Rev. 2016 Nov;49:106-118
pubmed: 27664823
Psychiatr Prax. 2001 Oct;28 Suppl 2:S84-90
pubmed: 11605129
J Affect Disord. 2002 Sep;71(1-3):1-9
pubmed: 12167495
Behav Sci (Basel). 2021 Jun 02;11(6):
pubmed: 34199633
J Epidemiol Community Health. 2014 Jan;68(1):78-82
pubmed: 24052515
Lancet. 1995 Feb 25;345(8948):524
pubmed: 7861901
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
BMC Public Health. 2015 Aug 01;15:738
pubmed: 26232123
Am J Mens Health. 2021 May-Jun;15(3):15579883211014776
pubmed: 34041980
Int Arch Occup Environ Health. 2018 May;91(4):435-443
pubmed: 29380045
Health (London). 2014 Jan;18(1):60-78
pubmed: 23426793
PLoS One. 2016 Aug 08;11(8):e0160740
pubmed: 27500969
Am J Mens Health. 2020 Jan-Feb;14(1):1557988320906980
pubmed: 32079448
Eur Neuropsychopharmacol. 2016 Jun;26(6):1004-13
pubmed: 27085517
J Affect Disord. 2004 May;80(1):87-93
pubmed: 15094262
J Epidemiol Community Health. 2008 Jan;62(1):42-7
pubmed: 18079332